← Open Payments lookup

REBECCA WAITE: Open Payments

NPI 1902333065 · VINEYARD, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$971 in 55 payments from 20 companies in 2025. Trend: 2023 $1,031 · 2024 $868 · 2025 $971

Food & beverage: $971
CompanyPaymentsAmount
ABBVIE INC.19$260
AstraZeneca Pharmaceuticals LP4$67
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$66
Organon LLC3$61
Corcept Therapeutics2$53
Lilly USA, LLC3$50
Takeda Pharmaceuticals U.S.A., Inc.2$50
PFIZER INC.3$46
Boehringer Ingelheim Pharmaceuticals, Inc.2$43
Novo Nordisk Inc2$43

Products named: VRAYLAR, QULIPTA, CAPLYTA, NEXPLANON, UBRELVY, Korlym, FARXIGA, TRINTELLIX.

Industry payments across UT — which companies pay providers there.